Bluejay Diagnostics (BJDX) Amortizatization of Intangibles (2020 - 2026)
Bluejay Diagnostics recorded quarterly Amortizatization of Intangibles of $21795.0 in Q1 2026, up 1.87% quarter-over-quarter from $21394.0 in Q4 2025, and down 34.92% year-over-year from $33492.0 in Q1 2025.
Bluejay Diagnostics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $21795.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 34.92% year-over-year to $21795.0; the TTM figure through Mar 2026 stood at $84802.0 (down 30.69% YoY), while the FY2025 annual figure was $96499.0, down 21.85% from the prior year.
- Amortizatization of Intangibles came in at $21795.0 for Q1 2026 at Bluejay Diagnostics, up from $21394.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $44555.0 in Q3 2022 to a low of $17611.0 in Q3 2023.
- A 5-year average of $30811.2 and a median of $33981.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 131.11% in 2022 and slumped 60.47% in 2023, its largest moves.
- Bluejay Diagnostics' Amortizatization of Intangibles stood at $38243.0 in 2022, then retreated by 11.14% to $33981.0 in 2023, then tumbled by 47.89% to $17707.0 in 2024, then gained by 20.82% to $21394.0 in 2025, then advanced by 1.87% to $21795.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $21795.0, $21394.0, and $21000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 75.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 21,795.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,795.00 |
| Mar 31, 2026 | 21,795.00 |
| Dec 31, 2025 | 21,394.00 |
| Dec 31, 2025 | 21,394.00 |
| Sep 30, 2025 | 21,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 20,613.00 |
| Jun 30, 2025 | 20,613.00 |
| Mar 31, 2025 | 33,492.00 |
| Mar 31, 2025 | 33,492.00 |
| Dec 31, 2024 | 17,707.00 |
| Dec 31, 2024 | 17,707.00 |
| Sep 30, 2024 | 35,907.00 |
| Sep 30, 2024 | 35,907.00 |
| Jun 30, 2024 | 35,253.00 |
| Jun 30, 2024 | 35,253.00 |
| Mar 31, 2024 | 34,612.00 |
| Mar 31, 2024 | 34,612.00 |
| Dec 31, 2023 | 33,981.00 |
| Dec 31, 2023 | 33,981.00 |
| Sep 30, 2023 | 17,611.00 |
| Sep 30, 2023 | 17,611.00 |
| Jun 30, 2023 | 40,327.00 |
| Jun 30, 2023 | 40,327.00 |
| Mar 31, 2023 | 40,328.00 |
| Mar 31, 2023 | 40,328.00 |
| Dec 31, 2022 | 38,243.00 |
| Dec 31, 2022 | 38,243.00 |
| Sep 30, 2022 | 44,555.00 |
| Sep 30, 2022 | 44,555.00 |
| Jun 30, 2022 | 38,734.00 |
| Jun 30, 2022 | 38,734.00 |
| Mar 31, 2022 | 28,238.00 |
| Mar 31, 2022 | 28,238.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2021 | -122,938.00 |
| Dec 31, 2020 | -69,183.00 |
| Dec 31, 2020 | -69,183.00 |
| Sep 30, 2020 | 29,167.00 |
| Sep 30, 2020 | 29,167.00 |